ArticleCureus2025
Prevalence of Molar Incisor Hypomineralization Among Children Aged Eight to 12 Years on Asthma Medication in Chengalpattu District, India: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Molar incisor hypomineralization (MIH), a defect in enamel development, is linked to early childhood illnesses. While respiratory infections correlate with increased MIH risk, the independent contribution of associated medications, particularly antibiotics, remains unclear, creating a significant knowledge gap. Aim The aim of the study is to investigate the prevalence of MIH in children aged eight to 12 years from Chengalpattu district, Tamil Nadu, India, who used asthmatic medication during their first three years of life. Materials and methods A cross-sectional study was conducted in the Chengalpattu district, examining 266 children aged eight to 12 years who had used asthmatic medication in their first three years of life. MIH was assessed using the European Archives of Pediatric Dentistry (EAPD) diagnostic criteria, and data were collected via structured questionnaires and clinical examinations at Chettinad Hospital and Research Institute. Data were analyzed using IBM SPSS Statistics software, version 24 (IBM Corp., Armonk, NY). Chi-square and Kolmogorov-Smirnov tests were employed to assess categorical data and normality, respectively, with a significance level of p < 0.05. Results A significant association (p < 0.001) was found between asthmatic medication use and MIH. Specifically, corticosteroid inhaler use was linked to a range of MIH clinical presentations and lesion severities, while beta-2 agonists combined with antihistamines were associated with more severe lesion extents. Conclusion This study concludes that a significant association exists between asthmatic medication, particularly corticosteroid inhalers and beta-2 agonist/antihistamine combinations, and MIH severity in children. Developing and implementing targeted oral health strategies, including early dental surveillance and preventive interventions, is crucial for mitigating MIH in asthmatic children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.